Brief: Huakang Biomedical Holdings Expects About 12.5% Decrease In Revenue For Nine Months

Joyzyme

24/10/2019 10:12

Oct 24 (Reuters) - Huakang Biomedical Holdings Co Ltd
 8622.HK :
    * EXPECTED TO RECORD A DECREASE IN REVENUE FOR NINE MONTHS
    * GROUP IS EXPECTED TO RECORD A DECREASE IN REVENUE FOR NINE
MONTHS
    * EXPECTED RESULT DUE TO  A DECREASE IN SALES TO SOME OF
CUSTOMERS
OF GROUP
    * SEES DECREASE IN PROFIT BEFORE LISTING EXPENSES FOR NINE
MONTHS
ENDED 30 SEPTEMBER 2019
    * EXPECTED TO RECORD A DECREASE IN REVENUE FOR NINE MONTHS
BY
ABOUT 12.5%
    * GROUP IS ALSO EXPECTED TO RECORD A DECREASE IN PROFIT
BEFORE
LISTING EXPENSES FOR NINE MONTHS
    * EXPECTED TO RECORD A DECREASE IN PROFIT BEFORE LISTING
EXPENSES
FOR NINE MONTHS BY ABOUT 73.1%

Source text for Eikon:  ID:nHKSbpyHF8 
Further company coverage:  8622.HK 

 ((Reuters.Briefs@thomsonreuters.com;))